Medibank Private needs an entity-specific source guide. Medibank brings a private-health specialist model and June financial year, with insurer, health-services, regulatory, and cyber-event reporting that differs sharply from multi-line P&C and life groups. The canonical company surface is the Medibank Private profile, while the references archive is the source-card record.
The qualified pack contains 4 cards across 4 source categories and 3 source owners or independently maintained paths. Its latest recorded reporting period is FY2025, year ended 2025-06-30. Those counts describe evidence coverage, not a score or a claim that every source measures the same thing.
Article Intelligence
- Primary company: Medibank Private.
- Canonical legal or group name: Medibank Private Limited.
- Entity type: Listed Australian private health insurer and health-services group.
- Home jurisdiction: Australia.
- Latest recorded report period: FY2025, year ended 2025-06-30.
- Source-pack depth: 4 cards, 4 categories, and 3 owners or paths.
- Canonical company archive: Medibank Private references.
Why This Source Map Is Distinct
Medibank's FY2025 report and results paths provide group and health-insurance measures; APRA and ASX paths supply independent regulated-industry and listed-company context. Together, the cards establish a route from identity and business scope to periodic reporting and capital, regulatory, ratings, exchange, or profile context. They do not merge those source types into one universal measure.
Reading The Source Categories
1. 2025 Annual Report / annual report
Owner: Medibank Private. Category: 2025 Annual Report / annual report. Reporting period: FY2025, year ended 2025-06-30. Entity scope: Medibank Group and named Health Insurance and Medibank Health segments. Evidence: Reported NPAT was AUD 500.8 million, underlying NPAT AUD 618.7 million, group operating profit AUD 762.4 million, health-insurance premium revenue AUD 8,211.0 million, and operating margin 9.0%. Caution: HTTP 200 official PDF reviewed. Underlying NPAT is non-GAAP and AASB 17 and cyber-event effects must remain explicit.
2. FY2025 Results Library / full-year results
Owner: Medibank Private. Category: FY2025 Results Library / full-year results. Reporting period: FY2025 results announced 2025-08-28. Entity scope: Medibank Group and disclosed segments. Evidence: The library provides Appendix 4E, financial report, investor presentation, and media release for the June 2025 year. Caution: HTTP 200 official page reviewed. Do not compare the June year-end directly with calendar-year peers without labels.
3. Private Health Insurance Statistics / regulatory context
Owner: Australian Prudential Regulation Authority. Category: Private Health Insurance Statistics / regulatory context. Reporting period: Quarterly regulatory series through the relevant FY2025 period. Entity scope: Australian private health insurance industry and regulated insurers. Evidence: APRA provides independent policyholder, premium, benefits, membership, and industry statistics used only when the exact quarter and denominator are stated. Caution: HTTP 200 regulator page reviewed. Industry statistics are not automatically Medibank company metrics.
4. Medibank Private Issuer Record / exchange record
Owner: Australian Securities Exchange. Category: Medibank Private Issuer Record / exchange record. Reporting period: Current issuer record reviewed 2026-07-15. Entity scope: Medibank Private Limited ASX code MPL. Evidence: The exchange path supports the listed parent, code, and announcement chain. Caution: Public exchange path reviewed. Exclude current security price, volume, and performance.
Reporting Periods And Company-Specific Facts
The source cards above contain the pack's principal numerical evidence from 2025 Annual Report / annual report, FY2025 Results Library / full-year results. Each fact remains inside its complete reporting-period and entity-scope record rather than being detached into a current-value table. Units, currencies, denominators, statutory or non-statutory labels, and issuer-defined terminology must remain exactly as the applicable card records them.
Period discipline matters here. A current profile page, an annual report, a regulatory return, a ratings page, and an exchange record can all be valid while answering different questions. The source date and reviewed date do not replace the underlying reporting period, and group totals cannot be moved to a subsidiary or business line without explicit support.
Entity Boundary
Use Medibank Private Limited as the listed parent and group. Medibank and ahm health-insurance brands, Medibank Health services, and other subsidiaries or businesses remain separately scoped; APRA private-health-insurance statistics use their own regulated perimeter. The Australian June year-end differs from calendar-year companies. Keep Health Insurance and Medibank Health segment measures, AASB 17 effects, and cyber-event costs separate. The guide therefore keeps the parent, consolidated group, operating insurers, brands, branches, joint ventures, and non-insurance businesses separate whenever the dossier identifies those distinctions.
What The Pack Can And Cannot Establish
The pack can establish source ownership, source category, accepted URL, reporting period, reviewed date, and the entity or segment scope stated on each card. It can also support the company-specific facts recorded in the dossier when their labels, units, currencies, denominators, and periods are preserved.
It cannot establish current security value, relative ranking, product suitability, available underwriting capacity, present pricing, placement terms, private treaty terms, or a standalone conclusion about solvency. Issuer-defined measures remain tied to the issuer's methodology and are not automatically comparable with similarly named measures from another insurer.
How To Use This Map
Start with the source category that matches the question. Use annual or full-year reporting for period-specific group facts, regulatory material for the named regulatory perimeter, ratings material for the named rated entity and opinion type, and exchange or corporate-profile material only for identity and public-record context. Then confirm the card's period, entity scope, unit, and caution before carrying any fact into another editorial surface.
Related Intelligence
- Medibank Private company profile for bounded company context.
- Medibank Private references for the complete source-card archive.
- Life and Health for source-supported line context.
- Methodology and Editorial Standards for InsureSouk source-handling rules.
Source Limitations
Public corporate, regulatory, exchange, filing, and ratings materials remain periodic and purpose-specific. They do not provide private underwriting files, policy terms, current placement information, or a complete view of every subsidiary. The entity and source-specific cautions recorded above remain controlling.
Reader Note
This article is editorial reference material. It is not a recommendation about an insurer, policy, product, security, rating, jurisdiction, or market. Readers making financial, insurance, legal, regulatory, underwriting, pricing, placement, or risk-management decisions should use current primary documents and appropriate professional review.
Sources and methodology
- 2025 Annual Report / annual report — Medibank Private. Reporting period: FY2025, year ended 2025-06-30. Entity scope: Medibank Group and named Health Insurance and Medibank Health segments.
- FY2025 Results Library / full-year results — Medibank Private. Reporting period: FY2025 results announced 2025-08-28. Entity scope: Medibank Group and disclosed segments.
- Private Health Insurance Statistics / regulatory context — Australian Prudential Regulation Authority. Reporting period: Quarterly regulatory series through the relevant FY2025 period. Entity scope: Australian private health insurance industry and regulated insurers.
- Medibank Private Issuer Record / exchange record — Australian Securities Exchange. Reporting period: Current issuer record reviewed 2026-07-15. Entity scope: Medibank Private Limited ASX code MPL.
- Medibank Private company profile. Used as the bounded company context surface.
- Medibank Private references archive. Expected to hold the source-reviewed cards created from this qualified dossier.
- Method. Only the accepted dossier sources are used. Numerical statements retain the recorded period and entity scope; no ranking, comparison table, recommendation, forecast, or current-capacity claim is created.